English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/126099
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice

AuthorsSoler-Llorens, Pedro; Zabalza-Baranguá, Ana ; San Román, Beatriz ; Grilló, María Jesús ; López-Goñi, Ignacio
Issue Date17-Jul-2014
PublisherEDP Sciences
CitationVeterinary Research 45(72): 1-11 (2014)
AbstractBrucella spp. are Gram-negative bacteria that behave as facultative intracellular parasites of a variety of mammals. This genus includes smooth (S) and rough (R) species that carry S and R lipopolysaccharides (LPS), respectively. S-LPS is a virulence factor, and mutants affected in the S-LPS O-polysaccharide (R mutants), core oligosaccharide or both show attenuation. However, B. ovis is naturally R and is virulent in sheep. We studied the role of B. ovis LPS in virulence by mutating the orthologues of wadA, wadB and wadC, three genes known to encode LPS core glycosyltransferases in S brucellae. When mapped with antibodies to outer membrane proteins (Omps) and R-LPS, wadB and wadC mutants displayed defects in LPS structure and outer membrane topology but inactivation of wadA had little or no effect. Consistent with these observations, the wadB and wadC but not the wadA mutants were attenuated in mice. When tested as vaccines, the wadB and wadC mutants protected mice against B. ovis challenge. The results demonstrate that the LPS core is a structure essential for survival in vivo not only of S brucellae but also of a naturally R Brucella pathogenic species, and they confirm our previous hypothesis that the Brucella LPS core is a target for vaccine development. Since vaccine B. melitensis Rev 1 is S and thus interferes in serological testing for S brucellae, wadB mutant represents a candidate vaccine to be evaluated against B. ovis infection of sheep suitable for areas free of B. melitensis.
DescriptionSoler-Llorens, Pedro et al.
Publisher version (URL)http://dx.doi.org/10.1186/s13567-014-0072-0
URIhttp://hdl.handle.net/10261/126099
DOI10.1186/s13567-014-0072-0
Identifiersdoi: 10.1186/s13567-014-0072-0
issn: 1297-9716
Appears in Collections:(IDAB) Artículos
Files in This Item:
File Description SizeFormat 
Mutants in the lipopolysaccharide_SolerLlorens.pdf678,56 kBAdobe PDFThumbnail
View/Open
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.